Astria Therapeutics, Inc. Deferred Offering Costs
Astria Therapeutics, Inc. had Deferred Offering Costs of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2025-03-11
- 2024-12-31: Deferred Offering Costs $0.00.
- 2023-12-31: Deferred Offering Costs $0.00.
- 2022-12-31: Deferred Offering Costs $0.00.
- 2021-12-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-04 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-22 |